Skip to main content
Clinical Trials/NCT05912374
NCT05912374CompletedNot Applicable

Implementing Cognitive Dysfunction Accommodation Strategies Into a Biobehavioral Pre-Exposure Prophylaxis (PrEP) Focused HIV Prevention Intervention for People Who Inject Drugs

University of Connecticut1 site in 1 country50 target enrollmentStarted: September 7, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
HIV risk reduction skills assessment at baseline

Study Overview

Brief Summary

The goal of this pilot work was to determine if the cognitive dysfunction accommodation strategies help patients retain/utilize more HIV prevention information and increase PrEP adherence. Fifty people who inject drugs (PWID) were prescribed PrEP and randomized to one of two conditions, Twenty-five PWID participated in a standard HIV prevention session and 25 other PWID participated in a HIV prevention session with the included accommodation strategies. At recruitment participants were asked to provide self-report of the screening form and cognitive functioning. The intervention consisted of a total of 5 sessions: 1 meeting to gain baseline information of participants and 4 intervention sessions. Participants completed the consent form, demographics, skills assessment, drug use behavior assessment, and HIV risk behavior assessment at the pre-interview meeting. Participants completed PrEP uptake assessments and skills assessments immediately following the intervention to compare the pre/post results between the two groups. All participants also completed an acceptability rating to help researchers determine the acceptability of the accommodation strategies used, at the end of the 4th session. The objective was to determine if the proposed accommodation strategies are feasible and efficacious at improving HIV prevention outcomes, including knowledge and skills. Information gleaned from this process will be used to refine the intervention approach for future testing and implementation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Participant)

Masking Description

single blind

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •at least 18 years or older
  • •reported injection drug use in the past 30 days
  • •reported engagement in drug- and/or sex- related HIV risk behaviors
  • •HIV negative
  • •are willing to initiate PrEP use
  • •can communicate (read, write and speak) in English
  • •experience mild/moderate level of cognitive dysfunction

Exclusion Criteria

  • •cannot attend all study sessions
  • •actively homicidal and/or suicidal

Arms & Interventions

Control arm with standard intervention

Active Comparator

Participants will complete a 4-week CHRP-BB standard intervention

Intervention: standard Community-Friendly Health Recovery Program- Biobehavioral (CHRP-BB) (Behavioral)

Experimental arm with enhanced intervention

Experimental

Participants will complete a 4-week CHRP-BB intervention enhanced with included cognitive dysfunction accommodation strategies.

Intervention: enhanced Community-Friendly Health Recovery Program- Biobehavioral (CHRP-BB) (Behavioral)

Outcomes

Primary Outcomes

HIV risk reduction skills assessment at baseline

Time Frame: pre intervention (week 0)

a 15 item checklist of HIV risk reduction skills, the lower the score the lower the ability to perform HIV risk reduction skills

number of participants who picked up PrEP prescription

Time Frame: post intervention (week 4)

PrEP prescription filled by pharmacy

HIV risk reduction skills assessment, post intervention

Time Frame: post intervention (week 4)

a 15 item checklist of HIV risk reduction skills, the lower the score the lower the ability to perform HIV risk reduction skills

Secondary Outcomes

  • number of participants retained throughout study(post intervention (week 4))
  • Intervention Acceptability(post intervention (week 4))
  • number of participants recruited(pre intervention (week 0))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michael Copenhaver

Professor

University of Connecticut

Study Sites (1)

Loading locations...

Similar Trials